HPV persistence can be measured as the time to clearance of an HPV type following its initial detection, with clearance defined as the first subsequent negative result (or preferably two sequential negative results) for that HPV type(6,8). The WLW and frailty models described above can be used to assess time to clearance of HPV on a type-specific basis(6,8).